Literature DB >> 18253758

Different BMI cardiovascular risk thresholds as markers of organ damage and metabolic syndrome in primary hypertension.

Mieczysław Litwin1, Joanna Sladowska, Małgorzata Syczewska, Anna Niemirska, Jadwiga Daszkowska, Jolanta Antoniewicz, Aldona Wierzbicka, Zbigniew T Wawer.   

Abstract

Obesity is the main intermediate phenotype of primary hypertension (PH), and increased fat mass is directly related to target organ damage (TOD) and metabolic syndrome (MS). The aim of the study was to assess the sensitivity and specificity of body mass index (BMI), percentile-based, definitions of obesity [BMI > 95th percentile (pc)], and overweight (BMI > 85th pc), and BMI thresholds for cardiovascular (cv) complications (BMIcv) described by Katzmarzyk et al. (Pediatrics 114:198-205, 2004) in predicting risk of TOD and MS in 122 adolescents with PH. Our results indicated that the prevalence of left ventricular hypertrophy (LVH) and carotid intima-media thickness (cIMT) above 2 standard deviations (SDS) was the same, irrespective of the criteria used. BMIcv was more sensitive as a marker of LVH than were the cut-off values of the 85th pc and 95th pc of BMI (87.5%, 75%, 62.5%, respectively; P < 0.0001). BMIcv thresholds and cut-off values of the 85th pc of BMI were of the same sensitivity in predicting the presence of MS (95.8% and 95.8%, respectively) and were more sensitive than the cut-off values of the BMI 95th pc (87.5%; P = 0.02). Metabolic abnormalities, including insulin resistance, were more marked in patients with greater BMI, irrespective of cut-off value. However, only when a stratification system using the 85th pc of BMI was used, were the differences significant for a homoeostasis model assessment for insulin resistance (HOMA-IR) and for serum concentrations of high-density lipoprotein (HDL)-cholesterol, triglycerides and adiponectin. We concluded that BMIcv is more sensitive for diagnosing the presence of LVH and that the cut-off value of the 85th pc of BMI is more sensitive for predicting presence of MS in children with PH.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18253758     DOI: 10.1007/s00467-007-0739-0

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  27 in total

1.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

2.  [Fat tissue distribution and metabolic alterations in boys with primary hypertension].

Authors:  Anna Niemirska; Mieczysław Litwin; Jolanta Antoniewicz; Elzbieta Jurkiewicz; Iwona Kościesza; Joanna Sladowska; Roman Janas; Zbigniew T Wawer
Journal:  Przegl Lek       Date:  2006

3.  Population-based examination of the interaction of primary hypertension and obesity in South Carolina.

Authors:  Abdullah Sakarcan; Jeanette Jerrell
Journal:  Am J Hypertens       Date:  2007-01       Impact factor: 2.689

4.  The metabolic syndrome and concentrations of C-reactive protein among U.S. youth.

Authors:  Earl S Ford; Umed A Ajani; Ali H Mokdad
Journal:  Diabetes Care       Date:  2005-04       Impact factor: 19.112

5.  Body mass index in primary and secondary pediatric hypertension.

Authors:  Renee F Robinson; Donald L Batisky; John R Hayes; Milap C Nahata; John D Mahan
Journal:  Pediatr Nephrol       Date:  2004-12       Impact factor: 3.714

6.  Utility of childhood BMI in the prediction of adulthood disease: comparison of national and international references.

Authors:  Ian Janssen; Peter T Katzmarzyk; Sathanur R Srinivasan; Wei Chen; Robert M Malina; Claude Bouchard; Gerald S Berenson
Journal:  Obes Res       Date:  2005-06

7.  Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk.

Authors:  G de Simone; R B Devereux; S R Daniels; M J Koren; R A Meyer; J H Laragh
Journal:  J Am Coll Cardiol       Date:  1995-04       Impact factor: 24.094

8.  Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight.

Authors:  G de Simone; S R Daniels; R B Devereux; R A Meyer; M J Roman; O de Divitiis; M H Alderman
Journal:  J Am Coll Cardiol       Date:  1992-11-01       Impact factor: 24.094

9.  Body mass index, waist circumference, and clustering of cardiovascular disease risk factors in a biracial sample of children and adolescents.

Authors:  Peter T Katzmarzyk; Sathanur R Srinivasan; Wei Chen; Robert M Malina; Claude Bouchard; Gerald S Berenson
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

10.  Prevalence and trends in overweight among US children and adolescents, 1999-2000.

Authors:  Cynthia L Ogden; Katherine M Flegal; Margaret D Carroll; Clifford L Johnson
Journal:  JAMA       Date:  2002-10-09       Impact factor: 56.272

View more
  7 in total

Review 1.  Autonomic nervous system dysregulation in pediatric hypertension.

Authors:  Janusz Feber; Marcel Ruzicka; Pavel Geier; Mieczyslaw Litwin
Journal:  Curr Hypertens Rep       Date:  2014-05       Impact factor: 5.369

2.  Ambulatory blood pressure monitoring and cardiac hypertrophy in children with metabolic syndrome.

Authors:  Berna Kamaci Bostanci; Mahmut Civilibal; Murat Elevli; Nilgun Selcuk Duru
Journal:  Pediatr Nephrol       Date:  2012-05-19       Impact factor: 3.714

3.  Subclinical atherosclerosis and ambulatory blood pressure in children with metabolic syndrome.

Authors:  Mahmut Civilibal; Nilgun Selcuk Duru; Murat Elevli
Journal:  Pediatr Nephrol       Date:  2014-06-07       Impact factor: 3.714

4.  Associations of cardiac structure with obesity, blood pressure, inflammation, and insulin resistance in African-American adolescents.

Authors:  Samuel S Gidding; Robert A Palermo; Stephanie S DeLoach; Scott W Keith; Bonita Falkner
Journal:  Pediatr Cardiol       Date:  2013-10-06       Impact factor: 1.655

5.  Left ventricular mass in normotensive, prehypertensive and hypertensive children and adolescents.

Authors:  Stella Stabouli; Vasilios Kotsis; Zoe Rizos; Savvas Toumanidis; Christince Karagianni; Andreas Constantopoulos; Nikos Zakopoulos
Journal:  Pediatr Nephrol       Date:  2009-05-15       Impact factor: 3.714

Review 6.  Intima-media thickness measurements in children with cardiovascular risk factors.

Authors:  Mieczysław Litwin; Anna Niemirska
Journal:  Pediatr Nephrol       Date:  2008-09-11       Impact factor: 3.714

Review 7.  Primary hypertension in children and adolescents is an immuno-metabolic disease with hemodynamic consequences.

Authors:  Mieczysław Litwin; Jacek Michałkiewicz; Lidia Gackowska
Journal:  Curr Hypertens Rep       Date:  2013-08       Impact factor: 5.369

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.